Have a feature idea you'd love to see implemented?
Let us know!
NTRA Natera Inc
Price (delayed)
$160.6
Market cap
$21.2B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.76
Enterprise value
$20.78B
Naterais a pioneer and global leader in cell-free DNA testing from a simple blood draw. The mission of the company is to change the management of disease worldwide with a
Highlights
Natera's gross profit has surged by 109% YoY and by 21% QoQ
The EPS has soared by 61% YoY and by 28% from the previous quarter
The company's debt rose by 10% QoQ and by 8% YoY
Key stats
What are the main financial stats of NTRA
Market
Valuations
Earnings
Shares outstanding
132.02M
Market cap
$21.2B
Enterprise value
$20.78B
Price to earnings (P/E)
N/A
Price to book (P/B)
22.61
Price to sales (P/S)
12.98
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
13.56
Revenue
$1.53B
Gross profit
$883.38M
Net income
-$214.69M
EBIT
-$199.9M
EBITDA
-$155.14M
Free cash flow
-$33.19M
Per share
Balance sheet
Liquidity
EPS
-$1.76
EPS diluted
-$1.76
Free cash flow per share
-$0.27
Book value per share
$7.1
Revenue per share
$12.38
TBVPS
$12.85
Total assets
$1.59B
Total liabilities
$712.42M
Debt
$465.97M
Equity
$878.53M
Working capital
$1.02B
Debt to equity
0.53
Current ratio
4.39
Quick ratio
4.08
Net debt/EBITDA
2.75
Margins
Efficiency
Dividend
EBITDA margin
-10.1%
Gross margin
57.7%
Net margin
-14%
Operating margin
-15.8%
Return on assets
-14.3%
Return on equity
-26.2%
Return on invested capital
-23.6%
Return on capital employed
-15.5%
Return on sales
-13%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
NTRA stock price
How has the Natera stock price performed over time
Intraday
1.45%
1 week
0.6%
1 month
-5.43%
1 year
159.37%
YTD
1.45%
QTD
1.45%
Financial performance
How have Natera's revenue and profit performed over time
Revenue
$1.53B
Gross profit
$883.38M
Operating income
-$242.09M
Net income
-$214.69M
Gross margin
57.7%
Net margin
-14%
Natera's gross profit has surged by 109% YoY and by 21% QoQ
The company's net margin has surged by 72% YoY and by 35% QoQ
NTRA's operating margin has surged by 69% year-on-year and by 32% since the previous quarter
Natera's net income has soared by 57% YoY and by 27% from the previous quarter
Growth
What is Natera's growth rate over time
Valuation
What is Natera stock price valuation
P/E
N/A
P/B
22.61
P/S
12.98
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
13.56
The EPS has soared by 61% YoY and by 28% from the previous quarter
The stock's P/B is 73% more than its 5-year quarterly average of 13.1 and 57% more than its last 4 quarters average of 14.4
NTRA's equity is up by 12% year-on-year and by 5% since the previous quarter
NTRA's revenue has surged by 55% year-on-year and by 13% since the previous quarter
NTRA's price to sales (P/S) is 44% higher than its last 4 quarters average of 9.0 and 22% higher than its 5-year quarterly average of 10.6
Efficiency
How efficient is Natera business performance
The ROS has soared by 74% YoY and by 36% from the previous quarter
The ROE has soared by 64% YoY and by 29% from the previous quarter
The ROA has soared by 61% year-on-year and by 28% since the previous quarter
The return on invested capital has surged by 51% year-on-year and by 27% since the previous quarter
Dividends
What is NTRA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for NTRA.
Financial health
How did Natera financials performed over time
NTRA's total assets is 123% higher than its total liabilities
NTRA's total assets is up by 10% YoY and by 4.9% QoQ
NTRA's total liabilities is up by 8% year-on-year and by 4.7% since the previous quarter
The company's debt is 47% lower than its equity
NTRA's equity is up by 12% year-on-year and by 5% since the previous quarter
The company's debt rose by 10% QoQ and by 8% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.